Description
This preparation combines four peptides supplied as a single blend: BPC-157, a 15-amino-acid gastric-juice-derived sequence; TB-500, a synthetic fragment of thymosin beta-4; GHK-Cu, the copper-complexed tripeptide glycyl-L-histidyl-L-lysine; and KPV, the C-terminal tripeptide of alpha-melanocyte-stimulating hormone. It is supplied as a single 80mg lyophilised preparation for in-vitro work where these pathways are examined in one experimental condition, released against ≥99.0% HPLC purity with per-lot documentation.
Batch Documentation
Every batch of KLOW dispatched by Core Research is accompanied by a batch-specific Certificate of Analysis (CoA) confirming HPLC purity and ESI-MS identity. CoA documents are available via the Certificate of Analysis Portal.
Research Use Only — Not for Human or Veterinary Use
KLOW is supplied exclusively for in vitro and pre-clinical laboratory research. It is not a medicinal product, has not been approved for therapeutic use in any jurisdiction, and must not be administered to humans or animals. Procurement confirms the purchaser is a qualified researcher operating within an institutional or commercial laboratory setting.
